GMO Venture Tsushin Startup Support

Investment decisions are led by Masatoshi Kumagai, founder of GMO Internet Group, and Tomoyoshi Akashi, CEO of Bakumatsu Co. Ltd., who co-established the program. The structure suggests a collaborative decision-making process between an experienced internet founder and a dedicated startup operator. Given the 20% stake held by GMO VenturePartners, some degree of coordination with the VC arm's investment committee is likely, though the precise governance mechanics are not publicly detailed.

The entity is a joint venture in which GMO VenturePartners, Inc. holds a 20% stake. Masatoshi Kumagai serves as Group CEO of GMO Internet Group, the publicly traded parent, while co-leading this vehicle alongside Tomoyoshi Akashi. This creates a tiered structure: a public internet conglomerate sits at the top, a venture capital subsidiary holds part of the JV, and the JV itself deploys capital into startups, with Kumagai's influence threading through all layers.

The firm focuses on early-stage opportunities, spanning startup, seed, and early-growth rounds. It operates a generalist mandate, making it stage-agnostic within the broader venture lifecycle as long as the company aligns with GMO's digital ecosystem or the principals' domain expertise in internet infrastructure, fintech, and consumer tech.

The firm's headquarters and known portfolio focus are centered on Japan, consistent with the deep domestic networks of its principals. However, given GMO Internet Group's international operations in domains, hosting, and crypto, the vehicle is positioned to evaluate cross-border opportunities, particularly in Asian markets. Specific geographic allocations outside Japan have not been publicly disclosed.

Capital deployed by this vehicle originates from Masatoshi Kumagai's personal wealth, generated through his founding and leadership of GMO Internet Group — a publicly traded company that dominates Japan's domain registration and web-hosting market. The firm's structure suggests a blend of principal capital and potential co-investment from the GMO VenturePartners fund complex, though the exact ratio is not publicly broken out.